Quanterix Receives Funding from the Alzheimer's Drug Discovery Foundation to Accelerate Alzheimer's Disease Diagnostic Plasma Test Development Seite 1
29.03.2022 - Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health, today announced it has partnered with the Alzheimer’s Drug Discovery Foundation (ADDF) to accelerate ... Seite 1
Source: wallstreet-online.de